Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...
The first dimension is the most fundamental: statistical fidelity. It is not enough for synthetic data to look random. It must behave like real data. This means your distributions, cardinalities, and ...
MicuRx Pharmaceuticals, Inc. ("MicuRx"), a clinical-stage biopharmaceutical company focused on developing novel anti-infective therapies for drug-resistant bacterial infections, recently announced ...
Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...
The National Testing Agency (NTA) has issued a reminder to candidates to apply for the Common University Entrance Test Undergraduate (CUET UG) 2026 at the earliest. Eligible candidates can submit ...
As the new year takes shape, we look back at major changes in corporate governance law over the second half of 2025 as a harbinger of developments ...
The Jewett Lab has spent years reimagining biological processes to advance technological progress. Recently, the lab helped ...
Once-weekly CagriSema significantly reduced HbA1c and body weight vs semaglutide in patients with type 2 diabetes in the REIMAGINE 2 trial.
Market valued at $46.59B in 2024, projected 7.31% CAGR growth driven by bio-based adoption, detergent demand, and ...
Pegasystems released a new AI-powered capability last summer called Blueprint that could look at all kinds of inputs to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results